Full-Time

Director – Msat

Confirmed live in the last 24 hours

ElevateBio

ElevateBio

501-1,000 employees

Biotechnology for cell and gene therapies

Biotechnology
Healthcare

Expert

Waltham, MA, USA

BaseCamp Waltham site.

Category
Genomics
Biology Lab & Research
Biology & Biotech
Required Skills
SAP Products
Data Analysis
Requirements
  • Minimum Bachelor’s Degree in Engineering, Science, or related field. Master’s or Ph.D strongly preferred.
  • At least 12 years of experience in a MSAT, Process Development or GMP environment supporting complex biologics products. Experience in autologous gene or cell therapy a plus.
  • At least 5 years of managerial experience in hiring and managing direct reports.
  • Extensive experience in leading process validation and commercial manufacturing support.
  • Demonstrated ability and strength in leading cross-functional technical teams within a matrixed organization.
  • A strong technical leader who can problem solve while balancing business needs with technical risks within a regulated environment.
  • Strong knowledge of regulatory requirements (e.g., FDA, EMA) and industry standards (e.g., ICH guidelines).
  • Prior experience with regulatory submission and regulatory inspection is strongly preferred.
  • Experience with digital tools used in manufacturing operation (eg. eBR, SAP) and fundamental understanding of data and statistical analysis.
  • Excellent project management, organizational, and communication skills including communication with senior leadership and external stakeholders.
  • Experience working within a contract manufacturing or client service organization strongly preferred.
Responsibilities
  • Lead and manage commercial readiness and PPQ activities ensuring compliance with regulatory standards and company policies.
  • Design and establish process validation framework including creation of policies and SOPs in collaboration with key stakeholders such as quality assurance.
  • Collaborate with cross-functional teams, including external client teams as well as internal Quality, Regulatory Affairs, and Manufacturing, to ensure seamless execution of PPQ activities.
  • Oversee the preparation and review of PPQ protocols, reports, and related documentation.
  • Oversee the design and execution of supporting BLA enabling studies such as filter validation, shipping validation, aseptic process validation etc
  • Establish and oversee continued process verification (CPV) program using state of the art digital technologies
  • Support raw material and consumable program as a process SME
  • Establish and support life cycle management program for post approval changes.
  • Ensure successful delivery of commercial batches in partnership with Manufacturing, Supply Chain, Quality and supporting functions by providing technical oversight of manufacturing batch execution, deviation management, troubleshooting, and batch disposition.
  • Partner with CMC Regulatory and SMEs to develop content for regulatory submissions (INDs, BLAs, DMFs etc.)
  • Actively support PAI readiness and regulatory inspections of BaseCamp Waltham site.
  • Build and grow a team of talented engineers or scientists to support PPQ and future commercial batches.

ElevateBio focuses on biotechnology, specifically in cell and gene therapy. They use proprietary technologies like gene editing and induced pluripotent stem cells (iPSC) to develop and manufacture therapies, serving clients such as biotech companies and healthcare providers. Their unique approach combines manufacturing and therapeutic development, allowing them to create a wide range of therapies while fostering partnerships to advance their work. The goal of ElevateBio is to streamline the process of discovering, developing, and commercializing cell and gene therapies to facilitate scientific breakthroughs.

Company Stage

Series D

Total Funding

$1.2B

Headquarters

Waltham, Massachusetts

Founded

2017

Growth & Insights
Headcount

6 month growth

23%

1 year growth

16%

2 year growth

34%
Simplify Jobs

Simplify's Take

What believers are saying

  • ElevateBio's recent $401 million Series D financing round, led by prominent investors, positions the company for accelerated growth and innovation.
  • The collaboration with the University of Pittsburgh to build the BioForge facility will significantly expand their manufacturing capabilities and technological infrastructure.
  • Their partnerships and commercialization efforts, including potential earnouts up to $2.35 billion with Novo Nordisk, offer substantial financial and developmental opportunities.

What critics are saying

  • The highly competitive biotechnology sector requires continuous innovation and investment to maintain a leading position.
  • Dependence on strategic partnerships and collaborations may pose risks if these relationships encounter challenges or fail to deliver expected outcomes.

What makes ElevateBio unique

  • ElevateBio's integrated ecosystem of technologies and capabilities allows them to discover, develop, manufacture, and commercialize a broad spectrum of cell and gene therapies, setting them apart from competitors who may only focus on one aspect of the process.
  • Their strategic partnerships with industry leaders like Novo Nordisk and Kyverna Therapeutics enhance their technological and therapeutic development capabilities.
  • The company's proprietary technologies, such as gene editing and induced pluripotent stem cell (iPSC) platforms, provide a competitive edge in the biotechnology market.

Help us improve and share your feedback! Did you find this helpful?